Alison W. Tisdale

Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology

Jordan Paradise, E. Kokkoli, Ralph Hall, 2009, Journal of Law, Medicine & Ethics.

Strong Enrichment of Aromatic Residues in Binding Sites from a Charge-neutralized Hyperthermostable Sso7d Scaffold Library

Raja R Srinivas, B. Tidor, K. Wittrup, 2016, The Journal of Biological Chemistry.

A Raf-Competitive K-Ras Binder Can Fail to Functionally Antagonize Signaling

Ryan L. Kelly, M. Hemann, K. Wittrup, 2018, Molecular Cancer Therapeutics.

Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface.

Michael M. Schmidt, Bracken M. King, K. Wittrup, 2013, Structure.

Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.

E. Kokkoli, A. Garg, Eman Haidari, 2008, International journal of pharmaceutics.

PR_b functionalized stealth liposomes for targeted delivery to metastatic colon cancer.

E. Kokkoli, Rachel M. Levine, Maroof M. Adil, 2013, Biomaterials science.

Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences

Aliya Kuzhabekova, E. Kokkoli, G. Ramachandran, 2009, Journal of Law, Medicine & Ethics.

Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.

Ashish Garg, E. Kokkoli, A. Tisdale, 2008, International journal of pharmaceutics.